There are 2137 resources available
1951P - Niraparib and irinotecan combination in ATM-mutated colorectal cancer
Presenter: Pietro Paolo Vitiello
Session: E-Poster Display
Resources:
Abstract
1952P - Comprehensive profiling of MDM2 amplified gastrointestinal (GI) cancers
Presenter: Francesca Battaglin
Session: E-Poster Display
Resources:
Abstract
1953P - Gender and molecular aspects of targeted therapy recommendations for therapy refractory solid tumours: Data from the real-world precision medicine platform MONDTI
Presenter: Hossein Taghizadeh
Session: E-Poster Display
Resources:
Abstract
1954P - A pan-cancer analysis of double PIK3CA mutations
Presenter: Neil Vasan
Session: E-Poster Display
Resources:
Abstract
1955P - Survival benefits of larotrectinib in an integrated dataset of patients with TRK fusion cancer
Presenter: Raymond McDermott
Session: E-Poster Display
Resources:
Abstract
1956P - A real-world feasibility study of patients with solid tumours harbouring NRG1 gene fusions
Presenter: Ajeet Gajra
Session: E-Poster Display
Resources:
Abstract
1957P - Evaluation of a digital treatment assignment system on whole-exome sequencing data of pediatric cancer patients
Presenter: Barbara Vodicska
Session: E-Poster Display
Resources:
Abstract
1958P - Reflex screening of somatic BRCA1/2 identifies pathogenic mutations in non-ovarian and breast cancers
Presenter: Albert Grinshpun
Session: E-Poster Display
Resources:
Abstract
1959P - The landscape of targetable rearrangements in Chinese patients with gastrointestinal cancer
Presenter: Jia Wei
Session: E-Poster Display
Resources:
Abstract
1960P - Differential induction of gene expression may explain differences in reported adverse event profiles between the FGFR-inhibitors derazantinib and erdafitinib: An analysis in safety relevant normal tissues from urothelial cancer (UC) patient-derived mouse xenograft (PDX) models
Presenter: Paul McSheehy
Session: E-Poster Display
Resources:
Abstract